Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets.

Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.

• Industry

  • AI & Machine Learning
  • Biotechnology

• Milestones

  • Lux investment: 2016

• Founders

  • Chris Gibson, PhD
  • Blake Borgeson, PhD
  • Dean Li, PhD

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • Blake Borgeson discusses how the Recursion platform could achieve #100treatmentsby2025 and reduce human suffering. https://t.co/bdXgpjd6dC@RecursionPharma - 08:06 PM Jun 1st
  • "Training computers to do something in 10 minutes that might take humans years." Read more: https://t.co/4ix7qhONe6… https://t.co/NOMQSg4av9@RecursionPharma - 03:15 PM May 30th
  • The best and the brightest come to work at @RecursionPharma . Congrats to August Allen on this recognition! https://t.co/L8RJyDYZQB@RecursionPharma - 10:27 PM May 24th